GlassScriptPhysician profile
Alison C Patterson
NPI 1356584601
$2,030.94
in general payments reported to CMS, 2019-2025
22 companies · $52.93 in 2025
The $52.93 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $201 · 2021: $346 · 2022: $372 · 2023: $601 · 2024: $262 · 2025: $52.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $802 · Education: $99.99 · Entertainment: $14.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $801.69 |
| Education | $99.99 |
| Entertainment | $14.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $383.38 | 2019-2024 | |
| Astellas Pharma US INC | $367.88 | 2023-2024 | Veozah |
| Therapeuticsmd, INC. | $199.87 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $166.24 | 2019-2024 | |
| Exeltis, USA INC. | $164.31 | 2020-2025 | Slynd |
| Mayne Pharma Commercial LLC | $148.12 | 2021-2025 | |
| Coopersurgical, INC. | $91.55 | 2019-2023 | Paragard T 380a |
| Organon LLC | $87.79 | 2021-2024 | Nexplanon |
| Hologic Sales and Service, LLC | $81.98 | 2021-2024 | Thinprep 2000 Processor, Aptima |
| Avion Pharmaceuticals | $70.12 | 2020-2023 | Balcoltra |
| Daiichi Sankyo INC. | $55.20 | 2022 | |
| Amag Pharmaceuticals, INC. | $30.01 | 2019-2020 | |
| Lupin INC. | $28.10 | 2020-2021 | |
| Pfizer INC. | $27.75 | 2022-2023 | |
| Covidien LP | $26.89 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $17.06 | 2021 | |
| Roche Diagnostics Corporation | $15.56 | 2019 | |
| Sage Therapeutics, LLC | $14.73 | 2024 | |
| Argentum Medical | $14.65 | 2025 | |
| Merck Sharp & Dohme LLC | $14.16 | 2020 | |
| Meditrina | $12.95 | 2024 | |
| Medtronic, INC. | $12.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.